3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
5
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
17
Other hematologic neoplasm
5
Thoracic
1
Sarcoma
1
Plasma cell
1
Lymphoid
1
Gastrointestinal
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
354
Lymphoma
306
Lymphoma, Follicular
269
Lymphoma, Non-Hodgkin
170
Leukemia
138
Hodgkin Disease
135
Multiple Myeloma
130
Leukemia, Lymphocytic, Chronic, B-Cell
110
Lymphoma, Large B-Cell, Diffuse
108
Leukemia, Myeloid, Acute
98
Neoplasms
83
Lymphoma, Mantle-Cell
70
Burkitt Lymphoma
70
Myelodysplastic Syndromes
64
Breast Neoplasms
62
Lymphoma, T-Cell, Cutaneous
60
Lymphoma, B-Cell, Marginal Zone
59
Myeloproliferative Disorders
50
Mycosis Fungoides
50
Motor Activity
49
Lymphoma, Large-Cell, Immunoblastic
47
Sezary Syndrome
44
Neoplasms, Plasma Cell
42
Hematologic Neoplasms
41
Dementia
41
Primary Myelofibrosis
39
Leukemia, Myeloid, Chronic-Phase
38
Leukemia, Myeloid, Accelerated Phase
38
Congenital Abnormalities
38
Recurrence
37
Interventions
Positron Emission Tomography Computed Tomography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Febrile Neutropenia
×
Lymphoid
×
Clear all
NCT03429387
2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA
Completed
147 enrolled